IceCure Medical (ICCM) Beginning Cash Balance (2020 - 2025)

IceCure Medical (ICCM) has reported Beginning Cash Balance for 6 consecutive years, with $7.6 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Beginning Cash Balance fell 28.19% year-over-year to $7.6 million in Q4 2025; TTM through Dec 2025 was $7.6 million, a 28.19% decrease from a year earlier, with the FY2025 full-year figure at $7.6 million, down 28.19% from the prior year.
• Beginning Cash Balance was $7.6 million for Q4 2025 at IceCure Medical, down from $10.5 million in the prior quarter.
• Over five years, Beginning Cash Balance peaked at $25.6 million in Q2 2022 and troughed at $3.5 million in Q2 2021.
• A 5-year average of $14.9 million and a median of $10.5 million in 2024 frame the typical range for Beginning Cash Balance.
• Across the five-year window, Beginning Cash Balance surged 631.61% in 2022 and plunged 55.48% in 2024, its largest moves.
• Over 5 years, Beginning Cash Balance stood at $3.5 million in 2021, then surged by 631.61% to $25.6 million in 2022, then retreated by 7.66% to $23.7 million in 2023, then plunged by 55.48% to $10.5 million in 2024, then slipped by 28.19% to $7.6 million in 2025.
• The last three Beginning Cash Balance figures came in at $7.6 million (Q4 2025), $10.5 million (Q4 2024), and $10.5 million (Q2 2024), per Business Quant data.